Pfizer Inc (NYSE:PFE)

50.94
Delayed Data
As of 4:03pm ET
 +0.28 / +0.55%
Today’s Change
38.82
Today|||52-Week Range
61.71
-13.73%
Year-to-Date
Pfizer (PFE) Discloses Autoimmune Drug Deal With Priovant
10:42am / Zacks.com - Paid Partner Content
Should You Invest in the Vanguard Health Care ETF (VHT)?
Jun 28 / Zacks.com - Paid Partner Content
FDA Panel Recommends Modifying COVID Jabs to Target Omicron
8:44am / Zacks.com - Paid Partner Content
Is This Medical Therapeutics Company Worth Buying or a Major Risk?
Jun 28 / StockNews.com - Paid Partner Content
2 Dividend Stocks With Huge Passive Income Potential
5:41am / MotleyFool.com - Paid Partner Content
How Pfizer Plans to Unlock Another Mass-Market Vaccine
Jun 27 / MotleyFool.com - Paid Partner Content
Investors Need Not Be Alarmed by Drug Patent Expirations
Jun 28 / GuruFocus News - Paid Partner Content
Pfizer's (PFE) Omicron-Based COVID Shot Betters Immune Response
Jun 27 / Zacks.com - Paid Partner Content
Company News for Jun 28, 2022
Jun 28 / Zacks.com - Paid Partner Content
3 Reasons to Buy Novavax and 1 to Sell
Jun 27 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close50.66
Today’s open50.76
Day’s range50.67 - 51.44
Volume13,904,493
Average volume (3 months)26,728,915
Market cap$289.5B
Data as of 4:03pm ET, 06/29/2022

Growth & Valuation

Earnings growth (last year)+128.42%
Earnings growth (this year)+52.39%
Earnings growth (next 5 years)-2.70%
Revenue growth (last year)+93.97%
P/E ratio11.5
Price/Sales4.15
Price/Book3.76

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+1.51+0.99%
LLYEli Lilly and Co+5.43+1.71%
MRKMerck+0.86+0.94%
AZNAstraZeneca+0.96+1.46%
Data as of 5:40pm ET, 06/29/2022

Financials

Next reporting dateJuly 28, 2022
EPS forecast (this quarter)$1.79
Annual revenue (last year)$81.3B
Annual profit (last year)$22.1B
Net profit margin27.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts